CA2485394A1 - Lancing device with a floating probe for control of penetration depth - Google Patents
Lancing device with a floating probe for control of penetration depth Download PDFInfo
- Publication number
- CA2485394A1 CA2485394A1 CA002485394A CA2485394A CA2485394A1 CA 2485394 A1 CA2485394 A1 CA 2485394A1 CA 002485394 A CA002485394 A CA 002485394A CA 2485394 A CA2485394 A CA 2485394A CA 2485394 A1 CA2485394 A1 CA 2485394A1
- Authority
- CA
- Canada
- Prior art keywords
- lancet
- target site
- floating probe
- carriage
- lancing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 title claims abstract description 99
- 230000035515 penetration Effects 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims description 9
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000002411 adverse Effects 0.000 description 3
- 239000013060 biological fluid Substances 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15186—Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
- A61B5/15188—Constructional features of reusable driving devices
- A61B5/15192—Constructional features of reusable driving devices comprising driving means, e.g. a spring, for retracting the lancet unit into the driving device housing
- A61B5/15194—Constructional features of reusable driving devices comprising driving means, e.g. a spring, for retracting the lancet unit into the driving device housing fully automatically retracted, i.e. the retraction does not require a deliberate action by the user, e.g. by terminating the contact with the patient's skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150053—Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
- A61B5/150061—Means for enhancing collection
- A61B5/150068—Means for enhancing collection by tissue compression, e.g. with specially designed surface of device contacting the skin area to be pierced
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150503—Single-ended needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15103—Piercing procedure
- A61B5/15107—Piercing being assisted by a triggering mechanism
- A61B5/15113—Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15115—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
- A61B5/15117—Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising biased elements, resilient elements or a spring, e.g. a helical spring, leaf spring, or elastic strap
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15186—Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
- A61B5/15188—Constructional features of reusable driving devices
- A61B5/1519—Constructional features of reusable driving devices comprising driving means, e.g. a spring, for propelling the piercing unit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/48—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for varying, regulating, indicating or limiting injection pressure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Testing Or Measuring Of Semiconductors Or The Like (AREA)
- Surgical Instruments (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of Length, Angles, Or The Like Using Electric Or Magnetic Means (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
A lancing device includes a lancing mechanism, a floating probe and a pressure tip.
The lancing mechanism includes a lancet carriage, a lancet holder slidably connected to the lancet carriage, and a lancet attached to the lancet holder. The pressure tip of the lancing device is configured for engaging a target site and creating a target site bulge. The floating probe is adapted to floatably contact the target site bulge and to operatively interact with the lance carriage to control a penetration depth of the lancet into the target site bulge. A method for lancing a target site includes providing the lancing device describe above and contacting the pressure tip of the lancing device with the target site. The pressure tip is then urged towards the target site to create a target site bulge with the floating probe of the lancing device floating on a surface of the target site bulge. Next, the target site bulge is lanced while the floating probe operatively interacts with the lance carriage to control a penetration depth of the lancet.
The lancing mechanism includes a lancet carriage, a lancet holder slidably connected to the lancet carriage, and a lancet attached to the lancet holder. The pressure tip of the lancing device is configured for engaging a target site and creating a target site bulge. The floating probe is adapted to floatably contact the target site bulge and to operatively interact with the lance carriage to control a penetration depth of the lancet into the target site bulge. A method for lancing a target site includes providing the lancing device describe above and contacting the pressure tip of the lancing device with the target site. The pressure tip is then urged towards the target site to create a target site bulge with the floating probe of the lancing device floating on a surface of the target site bulge. Next, the target site bulge is lanced while the floating probe operatively interacts with the lance carriage to control a penetration depth of the lancet.
Description
PATENT
Attorney Docket No: LFS-5002 LANCING DEVICE WITH A FLOATING PROBE
FOR CONTROL OF PENETRATION DEPTH
BACKGROUND OF THE INVENTION
[0001] 1. Field of the Invention [0002] The present invention relates, in general, to lancing devices and, in particular, to lancing devices with penetration depth control and associated methods of use.
Attorney Docket No: LFS-5002 LANCING DEVICE WITH A FLOATING PROBE
FOR CONTROL OF PENETRATION DEPTH
BACKGROUND OF THE INVENTION
[0001] 1. Field of the Invention [0002] The present invention relates, in general, to lancing devices and, in particular, to lancing devices with penetration depth control and associated methods of use.
[0003] 2. Description of the Related Art [0004] Conventional lancing devices generally have a rigid housing and a lancet that can be armed and launched so as to briefly protrude from one end of the lancing device.
For example, conventional lancing devices can include a lancet that is mounted within a rigid housing such that the lancet is movable relative to the rigid housing along a longitudinal axis thereof. Typically, the lancet is spring loaded and launched, upon release of the spring, to penetrate (i.e., "lance") a target site (e.g., a dermal tissue target site). A biological fluid sample (e.g., a whole blood sample) can then be expressed from the penetrated target site for collection and analysis. Conventional lancing devices are described in U.S. Patent No. 5,730,753 to Morita, U.S. Patent No.
6,045,567 to Taylor et al. and U.S. Patent No. 6,071,250 to Douglas et al., each of which is incorporated fully herein by reference.
For example, conventional lancing devices can include a lancet that is mounted within a rigid housing such that the lancet is movable relative to the rigid housing along a longitudinal axis thereof. Typically, the lancet is spring loaded and launched, upon release of the spring, to penetrate (i.e., "lance") a target site (e.g., a dermal tissue target site). A biological fluid sample (e.g., a whole blood sample) can then be expressed from the penetrated target site for collection and analysis. Conventional lancing devices are described in U.S. Patent No. 5,730,753 to Morita, U.S. Patent No.
6,045,567 to Taylor et al. and U.S. Patent No. 6,071,250 to Douglas et al., each of which is incorporated fully herein by reference.
[0005] Lancing devices often include a cap that engages the target site. Such a cap has an aperture (i.e., opening), through which the lancet protrudes during use.
Typically, a distal end of the cap will be placed in contact with the target site during use. The profile of the distal end of the cap can be adapted for contact with predetermined target sites, such as fingers, earlobes, forearms and the abdomen.
Typically, a distal end of the cap will be placed in contact with the target site during use. The profile of the distal end of the cap can be adapted for contact with predetermined target sites, such as fingers, earlobes, forearms and the abdomen.
[0006] When a cap is contacted with a target site, pressure is usually applied to the target site prior to launch of the lancet. This pressure urges the cap against the target PATENT
Attorney Docket No. LFS-5002 site and creates a target site bulge within the opening of the cap. The lancet is then launched to penetrate the target site bulge.
Attorney Docket No. LFS-5002 site and creates a target site bulge within the opening of the cap. The lancet is then launched to penetrate the target site bulge.
[0007] When pressure is applied on a cap of a lancing device against a target site, however, the height of the resultant target site bulge can vary greatly depending on the dimensions of the cap's opening, the magnitude of applied pressure and various physical properties (e.g., elasticity) of the target site. Such variability in target site bulge height causes the penetration depth of the lancet into the target site bulge to vary, as well. Thus, a lancet can potentially penetrate too deeply in some circumstances and not deeply enough, or at all, in other circumstances. Still needed in the field, therefore, is a lancing device and associated method that provide for the control of penetration depth across target site bulges of various heights.
SUMMARY OF THE INVENTION
SUMMARY OF THE INVENTION
[0008] Lancing devices and associated methods according to embodiments of the present invention provide for the control of penetration depth across target site bulges of various heights.
[0009] A lancing device according to an exemplary embodiment of the present invention includes a lancing mechanism, a pressure tip and a floating probe.
The lancing mechanism includes a lancet carriage, a lancet holder slidably connected to the lancet carriage, and a lancet attached to the lancet holder. The pressure tip is configured for engaging a target site and creating a target site bulge. The floating probe is adapted to floatably contact the target site bulge and to operatively interact with the lance carriage to control a penetration depth of the lancet into the target site bulge.
The lancing mechanism includes a lancet carriage, a lancet holder slidably connected to the lancet carriage, and a lancet attached to the lancet holder. The pressure tip is configured for engaging a target site and creating a target site bulge. The floating probe is adapted to floatably contact the target site bulge and to operatively interact with the lance carriage to control a penetration depth of the lancet into the target site bulge.
[0010] Since the floating probe of lancing devices according to the present invention is adapted to float upon the target site bulge, the floating probe can provide mechanical feedback to the lance carriage, lancet holder and lancet such that the penetration depth PATENT
Attorney Docket No. LFS-5002 across target site bulges of various heights is essentially constant. In doing so, the floating probe fixes a position of the lancet carriage relative to the target site bulge, thus providing a constant penetration depth.
Attorney Docket No. LFS-5002 across target site bulges of various heights is essentially constant. In doing so, the floating probe fixes a position of the lancet carriage relative to the target site bulge, thus providing a constant penetration depth.
[0011] A method for lancing a target site according to an exemplary embodiment of the present invention includes providing a lancing device (according to the present invention as described herein) and contacting a pressure tip of the lancing device with the target site. The pressure tip is then urged towards the target site to create a target site bulge with a floating probe of the lancing device floating on a surface of the target site bulge. Next, the target site bulge is lanced while the floating probe operatively interacts with the lance carriage to control a penetration depth of the lancet.
BRIEF DESCRIPTION OF THE DRAWINGS
BRIEF DESCRIPTION OF THE DRAWINGS
[0012] A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings, of which:
[0013] FIG. 1 is a simplified, schematic, cross-sectional view of a lancing device according to an exemplary embodiment of the present invention, with a floating probe and a lancing mechanism of the lancing device in a rest position;
[0014] FIG. 2 is a simplified schematic, cross-sectional view of the lancing device of FIG. 1 with the floating probe and lancing mechanism in the act of being placed into an armed position;
[0015] FIGs. 3A and 3B are simplified schematic, cross-sectional views of the lancing device of FIG. 1 with the floating probe contacting a relatively-low target site bulge and a relatively-high target site bulge, respectively;
[0016] FIGs. 4A and 4B are simplified, schematic, cross-sectional views of the lancing device of FIG. 1 depicting lance penetration into a relatively-low target site bulge and a relatively-high target site bulge, respectively;
PATENT
Attorney Docket No. LFS-5002 [0017] FIGs. SA and SB are simplified, schematic, cross-sectional views of the lancing device of FIG. 1 depicting post-lancing sample collection from a relatively-low target site bulge and a relatively-high target site bulge, respectively;
PATENT
Attorney Docket No. LFS-5002 [0017] FIGs. SA and SB are simplified, schematic, cross-sectional views of the lancing device of FIG. 1 depicting post-lancing sample collection from a relatively-low target site bulge and a relatively-high target site bulge, respectively;
[0018] FIG. 6 is a simplified, schematic, cross-sectional view of a lancing device according to another exemplary embodiment of the present invention;
[0019] FIG. 7 is an exploded perspective view of a lancing device according to yet another exemplary embodiment of the present invention;
[0020] FIG. 8 is a simplified, schematic, cross-sectional view of the lancing device of FIG. 7; and [0021] FIG. 9 is a flow diagram illustrating a sequence of steps for lancing a target site according to the present invention.
DETAILED DESCRIPTION OF THE INVENTION
DETAILED DESCRIPTION OF THE INVENTION
[0022] FIG. 1 is a simplified, schematic cross-sectional view of a lancing device 100 according to an exemplary embodiment of the present invention. Lancing device includes a housing 102, a pressure tip 104, a lancing mechanism 106, floating probe 108, a floating probe spring 110 and a trigger button 112. In the embodiment of FIG. 1, pressure tip 104 is attached to housing 102.
[0023] Pressure tip 104 and floating probe 108 are generally, but are not limited to being, cylindrical in form with openings ( 104a and 108a, respectively) therethrough.
The openings within pressure tip 104 and floating probe 108 may be, but are not limited to, circular shape openings, square shape openings, triangular shape openings, C-shape openings, U-shape openings, hexagonal shape openings and an octagonal shape openings.
The openings within pressure tip 104 and floating probe 108 may be, but are not limited to, circular shape openings, square shape openings, triangular shape openings, C-shape openings, U-shape openings, hexagonal shape openings and an octagonal shape openings.
[0024] During use of lancing device 100, pressure tip 104 is pressed against a target site (e.g., a user's skin of a dermal tissue target site) such that pressure tip 104 engages (contacts) the target site and urges the target site into a target-site bulge (not shown in FIG. 1) within the opening of pressure tip 104.
PATENT
Attorney Docket No. LFS-5002 [0025] Lancing mechanism 106 includes a lancet carriage 114, a lancet holder 116 and a lancet 118. Lancing mechanism 106 also includes over-travel spring 120 and launcher spring 122. Lancet carriage 114 includes carnage latch 124 and a lancet holder over-travel stop feature 126. In addition, pressure tip 104 has a probe stop surface 128.
PATENT
Attorney Docket No. LFS-5002 [0025] Lancing mechanism 106 includes a lancet carriage 114, a lancet holder 116 and a lancet 118. Lancing mechanism 106 also includes over-travel spring 120 and launcher spring 122. Lancet carriage 114 includes carnage latch 124 and a lancet holder over-travel stop feature 126. In addition, pressure tip 104 has a probe stop surface 128.
[0026] Floating probe 108 of lancing device 100 is adapted to floatably contact a target site bulge (not shown in FIG. 1) and is configured to operatively interact with lance carriage 114 to control a penetration depth of lancet 118 into the target-site bulge.
However, the extent to which floating probe 108 can move is limited by floating probe spring 110 and probe stop surface 128.
However, the extent to which floating probe 108 can move is limited by floating probe spring 110 and probe stop surface 128.
[0027] In the embodiment of FIG. 1, the floating nature of floating probe 108 is due to floating probe 108 being slidable along a longitudinal axis of housing 102. In addition, lancet carnage 114 and lancet holder 116 are also slidable with respect to housing 102 along the same longitudinal axis. Furthermore, lancet holder 116 is slidably connected to lancet carriage 114.
[0028] Over-travel spring 120, launcher spring 122 and probe spring 110 are configured to control movement and positioning of the floating probe, lancet carriage and lancet holder in a manner described below.
[0029] Over-travel spring 120 and lancet holder over-travel stop feature 126 provide for lancet 118 to extend to a controlled penetration depth in a target site bulge before over-travel spring 120 returns lancet 118 to a fixed rest position. In this regard, it should be noted that the position of lancet holder over-travel stop feature 126 with respect to a target site bulge is operatively set by the interaction of floating probe 108 and lancet carriage 114 (as described further below). Therefore, floating probe 108 is able to provide mechanical feedback to the lancet carriage 114, lancet holder 116 and PATENT
Attorney Docket No. LFS-5002 lancet 118 such that the penetration depth across target site bulges of various heights is controlled and essentially constant.
Attorney Docket No. LFS-5002 lancet 118 such that the penetration depth across target site bulges of various heights is controlled and essentially constant.
[0030] Launcher spring 122 controls movement of the lancet carriage 114.
Floating probe spring 110 and the probe stop surface 128 serve to control the extent to which the floating probe 108 can move (i.e., float) relative to housing 102. Exemplary, but non-limiting, strengths of the launcher spring 122, over-travel spring 120 and floating probe spring 110 are in the range of 0.5-1.0 lbs of force, 0.2-0.3 lbs of force and approximately 0.2 lbs of force respectively.
Floating probe spring 110 and the probe stop surface 128 serve to control the extent to which the floating probe 108 can move (i.e., float) relative to housing 102. Exemplary, but non-limiting, strengths of the launcher spring 122, over-travel spring 120 and floating probe spring 110 are in the range of 0.5-1.0 lbs of force, 0.2-0.3 lbs of force and approximately 0.2 lbs of force respectively.
[0031] Pressure tip 104 can be formed of, for example, a rigid or a relatively resiliently deformable material, including, but not limited, to elastomeric materials, polymeric materials, polyurethane materials, latex materials, silicone materials and any combinations thereof. Floating probe 108 can be formed of any suitable material including, but not limited to, relatively rigid material such as acrylonitrile butadiene styrene plastic, injection moldable plastic, polystyrene and metallic materials.
[0032] The operation and various features of lancing device 100 are illustrated in FIGS.
2, 3A, 3B, 4A, 4B, SA and SB. FIG. 2 is a simplified schematic, cross-sectional view of lancing device 100 with the floating probe 108 and lancing mechanism 106 in the act of being placed into an armed position (e.g., immediately prior to use). In an armed position, the lancet carriage 114 is held in position against the biasing force of launcher spring 122 by interaction between carriage latch 124, housing 102 and trigger button 112. The arrows of FIG. 2 depict a direction in which floating probe 108 can be pushed in order to place lancet carriage 114 into a position where it is held against the biasing force of launcher spring 122 by interaction between carriage latch 124, housing 102 and trigger button 112 (i.e., into an armed position). Lancing device 100 can, however, be placed into an armed position by any methods known to one skilled in the art including, for example, use of an external slider (not shown) or a plunger (also not shown).
PATENT
Attorney Docket No. LFS-5002 [0033] FIGs. 3A and 3B are simplified schematic, cross-sectional views of the lancing device of FIG. 1 with the floating probe contacting a relatively-low target site bulge (denoted as B 1) and a relatively-high target site bulge (denoted as B2), respectively.
When lancing device 100 is in use and pressure tip 104 is applied against a target site, a target site bulge is created in the opening of pressure tip 104. The height of the target site bulge can vary depending on, for example, target site physical properties.
However, in both FIG. 3A and FIG. 3B, floating probe 108 rests upon the target site bulge (B1 and B2, respectively in the FIGs. 3A and 3B) and is configured to move (i.e., float) with the surface of the target site bulge, essentially independent of lancet carriage 114 and housing 102. Since the floating probe floats with the surface of the target site bulge, floating probe 108 serves to control the penetration depth of lancet 118 into the target site bulge (as explained in more detail below). One skilled in the art will recognize that floating probe 108 can be configured to essentially float (rest) on the surface of the target site bulge in the presence of floating probe spring 110.
This can be accomplished by, for example, selecting a floating probe spring with a spring constant that does not significantly interfere with the floating nature of the floating probe.
2, 3A, 3B, 4A, 4B, SA and SB. FIG. 2 is a simplified schematic, cross-sectional view of lancing device 100 with the floating probe 108 and lancing mechanism 106 in the act of being placed into an armed position (e.g., immediately prior to use). In an armed position, the lancet carriage 114 is held in position against the biasing force of launcher spring 122 by interaction between carriage latch 124, housing 102 and trigger button 112. The arrows of FIG. 2 depict a direction in which floating probe 108 can be pushed in order to place lancet carriage 114 into a position where it is held against the biasing force of launcher spring 122 by interaction between carriage latch 124, housing 102 and trigger button 112 (i.e., into an armed position). Lancing device 100 can, however, be placed into an armed position by any methods known to one skilled in the art including, for example, use of an external slider (not shown) or a plunger (also not shown).
PATENT
Attorney Docket No. LFS-5002 [0033] FIGs. 3A and 3B are simplified schematic, cross-sectional views of the lancing device of FIG. 1 with the floating probe contacting a relatively-low target site bulge (denoted as B 1) and a relatively-high target site bulge (denoted as B2), respectively.
When lancing device 100 is in use and pressure tip 104 is applied against a target site, a target site bulge is created in the opening of pressure tip 104. The height of the target site bulge can vary depending on, for example, target site physical properties.
However, in both FIG. 3A and FIG. 3B, floating probe 108 rests upon the target site bulge (B1 and B2, respectively in the FIGs. 3A and 3B) and is configured to move (i.e., float) with the surface of the target site bulge, essentially independent of lancet carriage 114 and housing 102. Since the floating probe floats with the surface of the target site bulge, floating probe 108 serves to control the penetration depth of lancet 118 into the target site bulge (as explained in more detail below). One skilled in the art will recognize that floating probe 108 can be configured to essentially float (rest) on the surface of the target site bulge in the presence of floating probe spring 110.
This can be accomplished by, for example, selecting a floating probe spring with a spring constant that does not significantly interfere with the floating nature of the floating probe.
[0034] FIGs. 4A and 4B are simplified, schematic, cross-sectional views of lancing device 100 depicting lance penetration into the relatively-low target site bulge B 1 and the relatively-high target site bulges B2 of FIGS. 3A and 3B, respectively.
Once pressure tip 104 has been applied to a target site and a target site bulge created, operation of trigger button 112 (depicted by the arrow in FIG. 4A) releases carriage latch 124.
Once pressure tip 104 has been applied to a target site and a target site bulge created, operation of trigger button 112 (depicted by the arrow in FIG. 4A) releases carriage latch 124.
[0035] Release of carriage latch 124 allows lancet carriage 114, lancet holder 116 and lancet 118 to move (i.e., to be launched) toward the target site bulge under the force of launcher spring 122. Subsequently, lancet carriage 114 is stopped by contact with floating probe 108. The inertia of the lancet carriage may push the floating probe against the target site bulge, however this effect is a momentary deflection that is not expected to adversely affect operation of the lancing device.
PATENT
Attorney Docket No. LFS-5002 [0036] Due to the inertia of lancet holder 116, lancet holder 116 and lancet continue moving toward the target site bulge resulting in lancet 118 penetrating the target site bulge. This penetration is depicted in FIGs. 4A and 4B. Lancet holder over-travel stop feature 126 limits the distance that lancet holder 116 and lancet 118 can travel (to, for example, a distance in the range of 0.25 to 1.5 mm) once lancet carriage 114 has been stopped by contact with floating probe 108. The distance that lancet holder 116 and lancet 118 travel once lancet carriage 114 has been stopped is referred to as the over-travel distance. In the embodiment of FIGS. 1-SB, the over-travel distance is a fixed distance.
PATENT
Attorney Docket No. LFS-5002 [0036] Due to the inertia of lancet holder 116, lancet holder 116 and lancet continue moving toward the target site bulge resulting in lancet 118 penetrating the target site bulge. This penetration is depicted in FIGs. 4A and 4B. Lancet holder over-travel stop feature 126 limits the distance that lancet holder 116 and lancet 118 can travel (to, for example, a distance in the range of 0.25 to 1.5 mm) once lancet carriage 114 has been stopped by contact with floating probe 108. The distance that lancet holder 116 and lancet 118 travel once lancet carriage 114 has been stopped is referred to as the over-travel distance. In the embodiment of FIGS. 1-SB, the over-travel distance is a fixed distance.
[0037] Since the floating probe rests upon the surface of the target site bulge, regardless of whether the target site bulge is relatively high or relatively low, and serves to stop the movement of lancet carriage 114, penetration depth is consistently controlled across various target site bulge heights.
[0038] FIGs. SA and SB are simplified, schematic, cross-sectional views of lancing device 100 depicting post-lancing sample collection from the relatively-low target site bulge B 1 and a relatively-high target site bulge B2 of FIGs. 4A and 4B, respectively.
Following penetration of the target site bulge by lancet 118 (as depicted in FIGs. 4A
and 4B), the biasing force of over-travel spring 120 moves lancet holder 116 and lancet 118 to a position wherein lancet 118 is near or just below the surface of the target site bulge, e.g. to a depth of approximately 0.05 to 0.25 mm below the surface of the target site bulge. FIGs. SA and SB depict the presence of a biological fluid sample S
(e.g., whole blood) that has been expressed from the target site bulge. This biological fluid sample is available for transfer to a test strip (not shown) for analyte detection.
Following penetration of the target site bulge by lancet 118 (as depicted in FIGs. 4A
and 4B), the biasing force of over-travel spring 120 moves lancet holder 116 and lancet 118 to a position wherein lancet 118 is near or just below the surface of the target site bulge, e.g. to a depth of approximately 0.05 to 0.25 mm below the surface of the target site bulge. FIGs. SA and SB depict the presence of a biological fluid sample S
(e.g., whole blood) that has been expressed from the target site bulge. This biological fluid sample is available for transfer to a test strip (not shown) for analyte detection.
[0039] FIG. 6 is a simplified, schematic, cross sectional view of a lancing device 600 according to another exemplary embodiment of the present invention. In FIG. 6, lancing device 600 is depicted in an armed position and as pressed against a target site bulge (TB). Lancing device 600 includes a housing 602, a pressure tip 604, a lancing PATENT
Attorney Docket No. LFS-5002 mechanism 606, floating probe 608, floating probe spring 610 and a stop lock assembly 612 (with the dashed lines indicating a flexed position of stop lock assembly 612).
Attorney Docket No. LFS-5002 mechanism 606, floating probe 608, floating probe spring 610 and a stop lock assembly 612 (with the dashed lines indicating a flexed position of stop lock assembly 612).
[0040] Lancing mechanism 606 includes a lancet carriage 614, a lancet holder 616 and a lancet 618. Lancing mechanism 606 also includes launcher spring 620 and lancet carriage 614 includes a carriage latch 624.
[0041] Pressure tip 604 of lancing device 600 is depicted as an elastomeric cap, such as the cap described in U.S. Provisional Patent Application No. 60/426,683, which is hereby fully incorporated herein by reference. However, any suitable pressure tip known to those of skill in the art can be employed in embodiments of lancing devices according to the present invention.
[0042] Stop lock assembly 612 can be employed to prevent the floating probe from moving after launching of the lancet carriage 614, thereby reducing the impact force between the lancet carriage and the floating probe. This is accomplished by pushing stop lock assembly 612 (in the direction of the arrow in FIG. 6) such that stop lock assembly teeth 612A engage floating probe 608. Once stop lock assembly teeth 612A have engaged floating probe 608, floating probe 608 is prevented from moving.
Further pushing of stop lock assembly 612 places stop lock assembly into a flexed position (indicated by the dashed lines in FIG. 6) such that it can operatively interact with carriage latch 624.
Further pushing of stop lock assembly 612 places stop lock assembly into a flexed position (indicated by the dashed lines in FIG. 6) such that it can operatively interact with carriage latch 624.
[0043] FIGS. 7 and 8 are perspective exploded and cross-sectional views, respectively, of a lancing device 700 according to another exemplary embodiment of the present invention. Lancing device 700 includes a pressure tip 702, front housing 704, floating probe 706, dowel pins 708, lancet 710, floating probe spring 712, lancet holder 714, rest adjust nut 716, lancet carriage 718, launcher spring 720, decoupling spring spacer 722, decoupling spring 724, rear housing 726, trigger button 728, over-travel spring 730 and plunger 732.
PATENT
Attorney Docket No. LFS-5002 [0044] Pressure tip 702 is illustrated as having the form of an elastomeric cap, such as the elastomeric cap described in U.S. Provisional Patent Application No.
60/426,683, which is fully incorporated herein by reference. In the embodiment of FIGs. 7 and 8, decoupling spring 724 is operatively "in line" with the launcher spring 720.
Therefore, decoupling spring 724 is functionally in series with the launcher spring 720.
PATENT
Attorney Docket No. LFS-5002 [0044] Pressure tip 702 is illustrated as having the form of an elastomeric cap, such as the elastomeric cap described in U.S. Provisional Patent Application No.
60/426,683, which is fully incorporated herein by reference. In the embodiment of FIGs. 7 and 8, decoupling spring 724 is operatively "in line" with the launcher spring 720.
Therefore, decoupling spring 724 is functionally in series with the launcher spring 720.
[0045] Decoupling spring 724 is selected to have a much lower spring load than the launcher spring 720. For example, decoupling spring 724 can have a spring load at equilibrium in the range of 0.1 to 0.2 lbs. Decoupling spring 724 serves to reduce the cumulative force on floating probe 706. In the absence of decoupling spring 724, the spring force on floating probe 706 would be a result of the combined forces of floating probe spring 712 and the launcher spring 720. This combined force would cause an increase in the effective spring rate at the floating probe 706 that could adversely affect the operational characteristics of pressure tip 702. However, decoupling spring reduces the combined force and, therefore, eliminates such adverse affects. For example, when launcher spring 720 is extended during use, decoupling spring 724 acts to reduce the force applied by launcher spring 720 against lancet carriage 718.
[0046] Lancing device 700 is configured such that it can be placed into an armed position by retraction of plunger pull 732. Trigger button 728 can, thereafter, be employed to initiate launching of lancet carriage 718 and lancet holder 714.
[0047] Rest adjust nut 716 is adapted to adjust the lancet rest position, while dowel pins 708 are configured for locking floating probe 706 into a fixed position.
Rest adjust nut 716 allows the user to adjust the post-launching rest position of the lancet 710 relative to the floating probe 706. This adjustment enables placement of the lancet tip in a position that facilitates the transfer of a sample onto a test strip (not shown) integrated with the lancet. Optimal placement of a lancet after lancing is described in PATENT
Attorney Docket No. LFS-5002 more detail in US Provisional Application No. 60/422,228, which is hereby incorporated herein by reference.
Rest adjust nut 716 allows the user to adjust the post-launching rest position of the lancet 710 relative to the floating probe 706. This adjustment enables placement of the lancet tip in a position that facilitates the transfer of a sample onto a test strip (not shown) integrated with the lancet. Optimal placement of a lancet after lancing is described in PATENT
Attorney Docket No. LFS-5002 more detail in US Provisional Application No. 60/422,228, which is hereby incorporated herein by reference.
[0048] Depth penetration control with lancing device 700 is accomplished by having a threaded connection (not shown) between the plunger pull 732 and the lancet holder 714. The depth control or over-travel is limited when the plunger pull 732 contacts the lancet carriage 718. By adjusting the gap between the plunger pull 732 and the lancet carriage 718, lancet depth control is achieved. Over-travel spring 730 returns the lancet to the rest position after lancing is complete.
[0049] The floating probe 706 can be locked into a fixed position by use of dowel pins 708. Placing the floating probe into a locked position disables the floating nature of the floating probe. However, such a locked position can be desirable when lancing device 700 is used to lance a target site that results in a relatively flat (i.e., essentially flat) target site bulge. One skilled in the art will also appreciate that the slots cut into front housing 704 can be designed to allow the floating probe 706 to move in an axial direction to a prescribed limit. Except as otherwise described or illustrated, lancing device 700 operates in essentially the same manner as that described with respect to the embodiment of FIGS. 1-5.
[0050] As will be appreciated by those skilled in the art, lancet devices according to the present invention greatly facilitate reproducible production of a fluid sample (e.g., a blood sample) at a puncture (lancing) site because of the consistent lancet penetration depth. For example, lancing device 700 was employed to lance various dermal tissue target sites (i.e., an index finger target site and a palm target site) that resulted in the creation of target site bulges of various heights. Although the height of the target site bulges differed by 3 mm to 4 mm, penetration depth was consistent, and a blood sample was successfully expressed, at each target site. This facilitates in-situ testing of a fluid sample by means of a fluid collection device (such as a test strip) that is introduced at the lancet penetration site just after a lancet has been retracted. Consistent proper lancet depth control can also result in less pain.
PATENT
Attorney Docket No. LFS-5002 [0051] Referring to FIG. 9, a method 900 for lancing a target site includes providing a lancing device according to the present invention as described above. Such a lancing device includes a lancet carriage, a lancet holder slidably connected to the lancet carriage, a lancet attached to the lancet holder, a floating probe, and a pressure tip for engaging the target site and creating a target site bulge. The floating probe of such a lancing device is adapted to floatably contact the target site bulge and is configured to operatively interact with the lance carriage to control a penetration depth of the lancet into the target site bulge, as set forth in step 910.
PATENT
Attorney Docket No. LFS-5002 [0051] Referring to FIG. 9, a method 900 for lancing a target site includes providing a lancing device according to the present invention as described above. Such a lancing device includes a lancet carriage, a lancet holder slidably connected to the lancet carriage, a lancet attached to the lancet holder, a floating probe, and a pressure tip for engaging the target site and creating a target site bulge. The floating probe of such a lancing device is adapted to floatably contact the target site bulge and is configured to operatively interact with the lance carriage to control a penetration depth of the lancet into the target site bulge, as set forth in step 910.
[0052] Next, at step 920, the pressure tip of the lancing device is contacted with the target site. Subsequently, the pressure tip is urged towards the target site, thereby creating target site bulge with the floating probe floating (resting) on a surface of the target site bulge, as set forth in step 930.
[0053] Next, the target site bulge is lanced with the lancet while the floating probe operatively interacts with the lance carriage to control a penetration depth of the lancet into the bulge, as set forth in step 940. If desired, movement of the floating probe during lancing can be prevented through the use of a stop lock assembly as described above. One skilled in the art will recognize that steps 910, 920, 930 and 940 have been effectively illustrated by FIGs. 2 through 4B above.
[0054] It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
Claims (11)
1. A lancing device comprising:
a lancing mechanism having:
a lancet carriage;
a lancet holder slidably connected to the lancet carriage; and a lancet attached to the lancet holder;
a floating probe; and a pressure tip for engaging a target site and creating a target site bulge;
wherein the floating probe is adapted to floatably contact said target site bulge and is configured to operatively interact with the lance carriage to control a penetration depth of the lancet into the bulge.
a lancing mechanism having:
a lancet carriage;
a lancet holder slidably connected to the lancet carriage; and a lancet attached to the lancet holder;
a floating probe; and a pressure tip for engaging a target site and creating a target site bulge;
wherein the floating probe is adapted to floatably contact said target site bulge and is configured to operatively interact with the lance carriage to control a penetration depth of the lancet into the bulge.
2. The lancing device of claim 1 further comprising:
a housing;
wherein the lancet carriage is slidably connected to the housing, the lancet holder is slidably connected to the lancet carriage and the floating probe is slidably connected to the housing.
a housing;
wherein the lancet carriage is slidably connected to the housing, the lancet holder is slidably connected to the lancet carriage and the floating probe is slidably connected to the housing.
3. The lancing device of claim 1, wherein the floating probe is formed from a rigid material.
4. The lancing device of claim 1, further comprising a launcher spring and a decoupling spring arranged in series.
5. The lancing device of claim 1, wherein the penetration depth is in the range of 0.25 to 1.5 mm.
6. The lancing device of claim 1 further comprising a stop lock assembly.
7. The lancing device of claim 2, wherein the lancing mechanism further includes an over-travel spring and a launcher spring, wherein the housing includes a floating probe spring, and wherein the floating probe spring, launcher spring and floating probe spring are configured to control movement and positioning of the floating probe, lancet carriage and lancet holder.
8. The lancing device of claim 1, wherein the pressure tip includes a probe stop surface.
9. The lancing device of claim 1, wherein the lancet carriage includes a lancet holder over-travel stop feature.
10. A method for lancing a target site, the method comprising:
providing a lancing device that includes:
a lancet carriage;
a lancet holder slidably connected to the lancet carriage; and a lancet attached to the lancet holder;
a floating probe; and a pressure tip for engaging a target site and creating a target site bulge;
wherein the floating probe is adapted to floatably contact said target site bulge and is configured to operatively interact with the lance carriage to control a penetration depth of the lancet into the bulge;
contacting the pressure tip with the target site;
urging the pressure tip towards the target site, thereby creating target site bulge such that the floating probe is floating on a surface of the target site bulge; and lancing the target site bulge with the lancet while the floating probe operatively interacts with the lance carriage to control a penetration of the lancet.
providing a lancing device that includes:
a lancet carriage;
a lancet holder slidably connected to the lancet carriage; and a lancet attached to the lancet holder;
a floating probe; and a pressure tip for engaging a target site and creating a target site bulge;
wherein the floating probe is adapted to floatably contact said target site bulge and is configured to operatively interact with the lance carriage to control a penetration depth of the lancet into the bulge;
contacting the pressure tip with the target site;
urging the pressure tip towards the target site, thereby creating target site bulge such that the floating probe is floating on a surface of the target site bulge; and lancing the target site bulge with the lancet while the floating probe operatively interacts with the lance carriage to control a penetration of the lancet.
11. The method of claim 10, wherein the providing step provides a lancing device that further includes a stop lock assembly and wherein the lancing step lances the target site bulge while the stop lock assembly prevents movement of the floating probe.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/690,083 | 2003-10-20 | ||
US10/690,083 US7481818B2 (en) | 2003-10-20 | 2003-10-20 | Lancing device with a floating probe for control of penetration depth |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2485394A1 true CA2485394A1 (en) | 2005-04-20 |
CA2485394C CA2485394C (en) | 2013-07-23 |
Family
ID=34423316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2485394A Expired - Fee Related CA2485394C (en) | 2003-10-20 | 2004-10-20 | Lancing device with a floating probe for control of penetration depth |
Country Status (17)
Country | Link |
---|---|
US (1) | US7481818B2 (en) |
EP (1) | EP1527736B1 (en) |
JP (1) | JP4727204B2 (en) |
KR (1) | KR101157812B1 (en) |
CN (1) | CN1608587B (en) |
AT (1) | ATE439083T1 (en) |
AU (1) | AU2004222739B2 (en) |
CA (1) | CA2485394C (en) |
DE (1) | DE602004022497D1 (en) |
ES (1) | ES2329900T3 (en) |
HK (1) | HK1073057A1 (en) |
IL (1) | IL164696A (en) |
MX (1) | MXPA04010359A (en) |
NO (1) | NO20044435L (en) |
RU (1) | RU2343831C2 (en) |
SG (2) | SG131939A1 (en) |
TW (1) | TWI374728B (en) |
Families Citing this family (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7885697B2 (en) | 2004-07-13 | 2011-02-08 | Dexcom, Inc. | Transcutaneous analyte sensor |
US6036924A (en) | 1997-12-04 | 2000-03-14 | Hewlett-Packard Company | Cassette of lancet cartridges for sampling blood |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) * | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7682318B2 (en) | 2001-06-12 | 2010-03-23 | Pelikan Technologies, Inc. | Blood sampling apparatus and method |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
EP1404233B1 (en) | 2001-06-12 | 2009-12-02 | Pelikan Technologies Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
ATE497731T1 (en) | 2001-06-12 | 2011-02-15 | Pelikan Technologies Inc | DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK |
EP1404235A4 (en) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
JP4149911B2 (en) | 2001-06-12 | 2008-09-17 | ペリカン テクノロジーズ インコーポレイテッド | Electric lancet actuator |
US10022078B2 (en) | 2004-07-13 | 2018-07-17 | Dexcom, Inc. | Analyte sensor |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7648468B2 (en) | 2002-04-19 | 2010-01-19 | Pelikon Technologies, Inc. | Method and apparatus for penetrating tissue |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7291117B2 (en) | 2002-04-19 | 2007-11-06 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7717863B2 (en) | 2002-04-19 | 2010-05-18 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7371247B2 (en) | 2002-04-19 | 2008-05-13 | Pelikan Technologies, Inc | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
EP1561421A4 (en) * | 2002-11-15 | 2010-01-20 | Arkray Inc | Lancet and needle insertion device |
US20040127818A1 (en) * | 2002-12-27 | 2004-07-01 | Roe Steven N. | Precision depth control lancing tip |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
ES2347248T3 (en) | 2003-05-30 | 2010-10-27 | Pelikan Technologies Inc. | PROCEDURE AND APPLIANCE FOR FLUID INJECTION. |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
WO2005037095A1 (en) | 2003-10-14 | 2005-04-28 | Pelikan Technologies, Inc. | Method and apparatus for a variable user interface |
US20050096686A1 (en) * | 2003-10-31 | 2005-05-05 | Allen John J. | Lancing device with trigger mechanism for penetration depth control |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
EP1726259B1 (en) * | 2004-03-15 | 2011-10-05 | Terumo Kabushiki Kaisha | Body fluid collecting device |
US7201723B2 (en) * | 2004-03-25 | 2007-04-10 | Roche Diagnostics Operations, Inc. | Pulsating expression cap |
EP1734864B1 (en) | 2004-04-10 | 2013-08-28 | F.Hoffmann-La Roche Ag | Method and system for taking body fluid |
US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
US20050277849A1 (en) * | 2004-06-10 | 2005-12-15 | Daniel Wong | Vacuum sample expression device |
US20060036187A1 (en) | 2004-06-30 | 2006-02-16 | Hester Vos | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
US7727166B2 (en) * | 2004-07-26 | 2010-06-01 | Nova Biomedical Corporation | Lancet, lancet assembly and lancet-sensor combination |
DE102004059491B4 (en) * | 2004-12-10 | 2008-11-06 | Roche Diagnostics Gmbh | Lancet device for creating a puncture wound and lancet drive assembly |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US8956291B2 (en) * | 2005-02-22 | 2015-02-17 | Admetsys Corporation | Balanced physiological monitoring and treatment system |
CA2598770C (en) * | 2005-03-03 | 2011-07-19 | Frank Deck | Puncturing system for withdrawing a body fluid |
EP1709906A1 (en) * | 2005-04-07 | 2006-10-11 | F. Hoffmann-La Roche Ag | Method and device for blood sampling |
US20070038148A1 (en) * | 2005-08-11 | 2007-02-15 | Joel Mechelke | Sampling module for extracting interstitial fluid |
JP4575257B2 (en) * | 2005-09-06 | 2010-11-04 | オリンパスメディカルシステムズ株式会社 | Tissue biopsy needle device |
US20070202186A1 (en) | 2006-02-22 | 2007-08-30 | Iscience Interventional Corporation | Apparatus and formulations for suprachoroidal drug delivery |
EP2010055B1 (en) | 2006-04-25 | 2018-01-10 | Facet Technologies, LLC | Lancing device with independent drive core |
US8016848B2 (en) * | 2006-06-15 | 2011-09-13 | Abbott Diabetes Care Inc. | Lancets and methods of use |
EP1897493B1 (en) * | 2006-09-04 | 2010-11-03 | Roche Diagnostics GmbH | Piercing system for withdrawing a bodily fluid |
US7824102B2 (en) * | 2006-12-09 | 2010-11-02 | Shenzhen Mindray Bio-Medical Electronics, Inc. | Thermometer quick linkage apparatus and method |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
US20090264911A1 (en) * | 2008-04-16 | 2009-10-22 | Kim Stanley I | Single-use disposable lancing apparatus and methods |
US20110137208A1 (en) * | 2008-07-24 | 2011-06-09 | Admetsys Corporation | Device and method for automatically sampling and measuring blood analytes |
US8092476B2 (en) * | 2008-08-14 | 2012-01-10 | Abbott Diabetes Care Inc. | Adjustable cap and lancing device and method of use |
US8123772B2 (en) * | 2008-08-14 | 2012-02-28 | Abbott Diabetes Care Inc. | Cap for lancing device with adjustable mode of operation |
EP2181651A1 (en) * | 2008-10-29 | 2010-05-05 | Roche Diagnostics GmbH | Instrument and system for producing a sample of a body liquid and for analysis thereof |
JPWO2010050350A1 (en) * | 2008-10-30 | 2012-03-29 | シスメックス株式会社 | Body fluid collecting device and puncture needle attaching / detaching member used in this device |
JP5366195B2 (en) * | 2009-01-30 | 2013-12-11 | テルモ株式会社 | Injection needle assembly and drug injection device |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
KR101120364B1 (en) * | 2009-06-30 | 2012-02-24 | 변남철 | Lancing device for blood-gathering |
WO2011002229A2 (en) * | 2009-06-30 | 2011-01-06 | Byun Nam Chul | Blood collecting device |
MX2012004446A (en) | 2009-10-16 | 2012-06-08 | Janssen Biotech Inc | Palm activated drug delivery device. |
US9233213B2 (en) | 2009-10-16 | 2016-01-12 | Janssen Biotech, Inc. | Palm activated drug delivery device |
JP5931847B2 (en) * | 2010-03-31 | 2016-06-08 | オキュジェクト, エルエルシー | Devices and methods for intraocular drug delivery |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
WO2011152580A1 (en) * | 2010-06-04 | 2011-12-08 | Shin Youn-Cheol | Device for preventing reuse of lancet |
JP5938403B2 (en) | 2010-07-02 | 2016-06-22 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Safety devices for drug-filled syringes and injection devices |
US9999384B2 (en) | 2011-03-09 | 2018-06-19 | Becton, Dickinson And Company | Sleeve for removable lancet of lancing device |
JP5930688B2 (en) * | 2011-12-09 | 2016-06-08 | アークレイ株式会社 | Lancet cartridge |
DE102011056626B4 (en) * | 2011-12-19 | 2014-02-13 | Gerresheimer Regensburg Gmbh | Lancing device for blood sampling |
WO2013155149A1 (en) | 2012-04-11 | 2013-10-17 | Facet Technologies, Llc | Lancing device with moving pivot depth adjust |
US9486166B2 (en) * | 2012-05-18 | 2016-11-08 | Panasonic Healthcare Holdings Co., Ltd. | Puncturing needle cartridge and puncturing instrument |
RU2015100111A (en) * | 2012-06-12 | 2016-08-10 | Т-Медикал Инновэйшионс Лтд. | DEVICE AND METHOD FOR PERFORMING THE FIRST SKIN CUT IN THE SURGERY AND FOR LABELING LINE ALONG THE CUT EDGE |
WO2014014235A1 (en) * | 2012-07-18 | 2014-01-23 | Park Jin Han | Blood-collection device |
US10646150B2 (en) * | 2013-03-12 | 2020-05-12 | Ascensia Diabetes Care Holdings Ag | Lancing device |
CN104127190A (en) * | 2013-05-03 | 2014-11-05 | 品强科技精密有限公司 | Blood sampling device allowing controllable puncturing depth |
SG10201702674PA (en) | 2013-05-03 | 2017-06-29 | Clearside Biomedical Inc | Apparatus and methods for ocular injection |
CN105771038B (en) * | 2016-03-17 | 2022-09-13 | 南京医科大学第一附属医院 | Accurate trace acupuncture point injection pen |
JP2019514581A (en) | 2016-05-02 | 2019-06-06 | クリアサイド バイオメディカル,インコーポレイテッド | Systems and methods for ocular drug delivery |
CN110177527B (en) * | 2016-08-12 | 2022-02-01 | 科尼尔赛德生物医学公司 | Device and method for adjusting insertion depth of needle for medicament delivery |
CN106409073A (en) * | 2016-12-16 | 2017-02-15 | 青岛海之源智能技术有限公司 | Teaching apparatus for physical characteristic of ellipse |
CN108414298B (en) * | 2018-03-16 | 2021-11-23 | 广东美味鲜调味食品有限公司 | Gas sampling device |
DE112019004738T5 (en) * | 2018-09-21 | 2021-06-02 | Actuated Medical, Inc. | Lancet device with anesthesia function |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2642896C3 (en) * | 1976-09-24 | 1980-08-21 | 7800 Freiburg | Precision snapper for setting standard stab wounds in the skin for diagnostic purposes |
US4449529A (en) * | 1981-11-18 | 1984-05-22 | Becton Dickinson And Company | Automatic retractable lancet assembly |
US4517978A (en) * | 1983-01-13 | 1985-05-21 | Levin Paul D | Blood sampling instrument |
US4653513A (en) * | 1985-08-09 | 1987-03-31 | Dombrowski Mitchell P | Blood sampler |
DE4212315A1 (en) * | 1992-04-13 | 1993-10-14 | Boehringer Mannheim Gmbh | Blood lancet device for drawing blood for diagnostic purposes |
EP0783868B1 (en) * | 1995-07-28 | 2003-04-09 | Apls Co., Ltd. | Assembly for adjusting the piercing depth of a lancet |
DE19604156A1 (en) * | 1996-02-06 | 1997-08-07 | Boehringer Mannheim Gmbh | Skin cutting device for taking pain-free small amounts of blood |
US5951493A (en) * | 1997-05-16 | 1999-09-14 | Mercury Diagnostics, Inc. | Methods and apparatus for expressing body fluid from an incision |
US5857983A (en) * | 1996-05-17 | 1999-01-12 | Mercury Diagnostics, Inc. | Methods and apparatus for sampling body fluid |
US6332871B1 (en) * | 1996-05-17 | 2001-12-25 | Amira Medical | Blood and interstitial fluid sampling device |
US7235056B2 (en) * | 1996-05-17 | 2007-06-26 | Amira Medical | Body fluid sampling device and methods of use |
US6706000B2 (en) * | 1997-11-21 | 2004-03-16 | Amira Medical | Methods and apparatus for expressing body fluid from an incision |
US6022366A (en) * | 1998-06-11 | 2000-02-08 | Stat Medical Devices Inc. | Lancet having adjustable penetration depth |
US6045567A (en) * | 1999-02-23 | 2000-04-04 | Lifescan Inc. | Lancing device causing reduced pain |
US6306152B1 (en) | 1999-03-08 | 2001-10-23 | Agilent Technologies, Inc. | Lancet device with skin movement control and ballistic preload |
US6396158B1 (en) * | 1999-06-29 | 2002-05-28 | Motorola Inc. | Semiconductor device and a process for designing a mask |
WO2003005906A1 (en) | 2001-07-11 | 2003-01-23 | Arkray, Inc. | Piercing device |
JP4250698B2 (en) * | 2001-07-19 | 2009-04-08 | アークレイ株式会社 | Puncture device |
WO2003022331A2 (en) * | 2001-09-13 | 2003-03-20 | Facet Technologies, Llc | Adjustable depth lancing device |
US20040127818A1 (en) * | 2002-12-27 | 2004-07-01 | Roe Steven N. | Precision depth control lancing tip |
-
2003
- 2003-10-20 US US10/690,083 patent/US7481818B2/en not_active Expired - Fee Related
-
2004
- 2004-10-19 KR KR1020040083553A patent/KR101157812B1/en active IP Right Grant
- 2004-10-19 AU AU2004222739A patent/AU2004222739B2/en not_active Ceased
- 2004-10-19 AT AT04256423T patent/ATE439083T1/en not_active IP Right Cessation
- 2004-10-19 RU RU2004130732/14A patent/RU2343831C2/en not_active IP Right Cessation
- 2004-10-19 IL IL164696A patent/IL164696A/en active IP Right Grant
- 2004-10-19 NO NO20044435A patent/NO20044435L/en not_active Application Discontinuation
- 2004-10-19 TW TW093131651A patent/TWI374728B/en not_active IP Right Cessation
- 2004-10-19 EP EP04256423A patent/EP1527736B1/en not_active Not-in-force
- 2004-10-19 DE DE602004022497T patent/DE602004022497D1/en active Active
- 2004-10-19 ES ES04256423T patent/ES2329900T3/en active Active
- 2004-10-19 JP JP2004304609A patent/JP4727204B2/en not_active Expired - Fee Related
- 2004-10-20 MX MXPA04010359A patent/MXPA04010359A/en active IP Right Grant
- 2004-10-20 CN CN2004100959768A patent/CN1608587B/en not_active Expired - Fee Related
- 2004-10-20 CA CA2485394A patent/CA2485394C/en not_active Expired - Fee Related
- 2004-10-20 SG SG200702857-4A patent/SG131939A1/en unknown
- 2004-10-20 SG SG200406171A patent/SG111247A1/en unknown
-
2005
- 2005-07-07 HK HK05105723.8A patent/HK1073057A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2004222739B2 (en) | 2009-08-27 |
MXPA04010359A (en) | 2005-07-05 |
JP2005185825A (en) | 2005-07-14 |
KR101157812B1 (en) | 2012-06-22 |
CN1608587A (en) | 2005-04-27 |
DE602004022497D1 (en) | 2009-09-24 |
JP4727204B2 (en) | 2011-07-20 |
RU2004130732A (en) | 2006-03-20 |
SG111247A1 (en) | 2005-05-30 |
NO20044435L (en) | 2005-04-21 |
EP1527736B1 (en) | 2009-08-12 |
RU2343831C2 (en) | 2009-01-20 |
AU2004222739A1 (en) | 2005-05-05 |
US7481818B2 (en) | 2009-01-27 |
ES2329900T3 (en) | 2009-12-02 |
HK1073057A1 (en) | 2005-09-23 |
CN1608587B (en) | 2010-06-23 |
SG131939A1 (en) | 2007-05-28 |
KR20050037969A (en) | 2005-04-25 |
TW200526177A (en) | 2005-08-16 |
CA2485394C (en) | 2013-07-23 |
US20050085839A1 (en) | 2005-04-21 |
EP1527736A1 (en) | 2005-05-04 |
IL164696A (en) | 2009-12-24 |
TWI374728B (en) | 2012-10-21 |
ATE439083T1 (en) | 2009-08-15 |
IL164696A0 (en) | 2005-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2485394C (en) | Lancing device with a floating probe for control of penetration depth | |
EP1527737B1 (en) | Lancing device with trigger mechanism for penetration depth control | |
EP1031318B1 (en) | Lancing device causing reduced pain | |
US20070060842A1 (en) | Lancing cap kit applied pressure sensing cap | |
US8888804B2 (en) | Adjustable lancet device and method | |
US4527561A (en) | Automatic retractable lancet assembly | |
US20050234491A1 (en) | Method for lancing a dermal tissue target site employing a dermal tissue lancing device with a tiltable cap | |
US20050234490A1 (en) | Tiltable cap for a dermal tissue lancing device | |
JP6395123B2 (en) | Method and apparatus for sensor insertion | |
US20070083222A1 (en) | Lancet device, removal system for lancet device, and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20201020 |